Roche pharmaceuticals news

Roche restructured its R&D programs by eliminating work on antibiotics, antifungals, dermatology, transplant and most cardiovascular indications. Remaining research will be focused on inflammation, virology, oncology, metabolic diseases and central nervous system disorders. ...